Bill Text: NY A08345 | 2023-2024 | General Assembly | Amended

---

Bill Title: Directs the department of health to report to the legislature on the feasibility of entering into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs; makes related provisions.

Spectrum: Partisan Bill (Democrat 3-0)

Status: (Introduced) 2024-05-21 - reported referred to ways and means [A08345 Detail]

Download: New_York-2023-A08345-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         8345--B

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                    December 13, 2023
                                       ___________

        Introduced  by  M.  of A. RAJKUMAR, L. ROSENTHAL, SEAWRIGHT -- read once
          and referred to the Committee on Health -- recommitted to the  Commit-
          tee  on Health in accordance with Assembly Rule 3, sec. 2 -- committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee -- again reported from said  committee  with  amend-
          ments, ordered reprinted as amended and recommitted to said committee

        AN  ACT  in  relation to requiring the department of health to report on
          the feasibility of establishing a generic drug  manufacturing  program
          aimed at reducing the cost of prescription drugs and to address short-
          ages in the market for generic prescription drugs

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. On or before January first, two  thousand  twenty-six,  the
     2  department  of  health  shall  submit  a  report to the legislature that
     3  assesses the feasibility of establishing a  generic  drug  manufacturing
     4  program  aimed at reducing the cost of prescription drugs and to address
     5  shortages in the market for generic prescription drugs by directly manu-
     6  facturing generic prescription drugs and  selling  generic  prescription
     7  drugs  at  a  fair price. The report shall conduct an analysis of gover-
     8  nance structure options for manufacturing functions, including  charter-
     9  ing  a  private  organization, a public-private partnership, or a public
    10  board of directors.  Additionally, the report shall include, but not  be
    11  limited to an analysis of the:
    12    (a) feasibility of entering into a partnership with a drug manufactur-
    13  er to produce insulin and generic drugs for chronic and high-cost condi-
    14  tions;
    15    (b) feasibility of entering into a partnership with a drug manufactur-
    16  er to produce and make generic prescription drugs widely available;
    17    (c)  generic prescription drugs that would have the greatest impact on
    18  lowering drug costs to patients, including high-cost drugs, high  utili-

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08090-04-4
        A. 8345--B                          2

     1  zation  drugs,  or  drugs experiencing shortages in the market which the
     2  program may prioritize;
     3    (d)  amount  of  staff required to oversee and manage the partnerships
     4  for manufacturing or distribution of generic prescription drugs;
     5    (e) research and development costs and start up costs associated  with
     6  the generic drug manufacturing program; and
     7    (f)  volume  of  generic  prescription  drugs  and insulin that can be
     8  produced over the first five years of the program.
     9    § 2. This act shall take effect on the first of January next  succeed-
    10  ing one year after it shall have become a law.